Form 4: Organon & Co. Executive Reports Stock Transactions
SEC Form 4 Filing
Chief Human Resources Officer Aaron Falcione reports the vesting of restricted stock units and subsequent stock sales.
Summary
- On May 4, 2024, Aaron Falcione, Chief Human Resources Officer of Organon & Co., reported transactions involving Organon's common stock.
- 2,770 restricted stock units (RSUs) vested, converting into 2,770 shares of common stock.
- Falcione disposed of 949 shares of common stock at a price of $19.6, resulting in a decrease in holdings.
- Following these transactions, Falcione directly owns 30,415 shares of Organon common stock.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions, with no inherent positive or negative implications for the company's performance.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common practice for publicly traded companies. It provides transparency into the executive's holdings and transactions in the company's stock.
Stakeholder Impact
- The transactions have a minimal impact on shareholders as they represent a small portion of the overall outstanding shares.
- The filing provides transparency to stakeholders regarding executive compensation and stock ownership.
Key Dates
| Date | Description |
|---|---|
| 05/04/2022 | One-third of the RSUs vested. |
| 05/04/2023 | One-third of the RSUs vested. |
| 05/04/2024 | One-third of the RSUs vested; stock transactions occurred. |
| 05/07/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.